Application Nr Approved Date Route Status External Links
ANDA077558 2017-05-05 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lamivudine And Zidovudine Tablets, A Combination Of 2 Nucleoside Analogues, Are Indicated In Combination With Other Antiretrovirals For The Treatment Of Human Immunodeficiency Virus Type 1 (hiv-1) Infection. Lamivudine And Zidovudine Tablets, A Combination Of 2 Nucleoside Analogue Reverse Transcriptase Inhibitors, Are Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. (1)

All Formulated Excipients (6 Total)

Name Structure Kind Function Status
1. Silicon Dioxide SILICON DIOXIDE Unresolved AC-Anticaking agent , MISC-Miscellaneous , STAB-Stabilizer GRAS-Generally recognized as safe.
2. Hypromelloses HYPROMELLOSES Unresolved
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
5. Polyethylene Glycols POLYETHYLENE GLYCOLS Unresolved
6. Polysorbate 80 POLYSORBATE 80 Unresolved AF-Antifoaming (or defoaming) agent , EMUL-Emulsifier , MISC-Miscellaneous , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Lamivudine LAMIVUDINE ZINC12346
2. Zidovudine ZIDOVUDINE ZINC3779042

Comments